Since it was reported in the literature that the HDAC inhibitor trichostatin A could transform the ovarian carcinoma cells [13], we treated cells with trichostatin A and found that cells got transformed in a similar way as with 15dPGJ2 (Fig. 5A). Here, HDAC9 is linked to ovarian carcinoma.